Nazia Habib
Internal Medicine · Albany, NYNPI 1356433858
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 82 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $824 and has fallen 97.7% since, to $19 in 2025.
Across 82 payments — averaging $15.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$234
- Novo Nordisk$181
- Pfizer$140
- Merck$126
- AbbVie$88
- Novartis$69
- plus $449 from 18 others
What the payments were for
- Speaking & faculty fees$141%
- Food & beverage$1,27399%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 15 | $234 |
| Novo Nordisk | 10 | $181 |
| Pfizer | 13 | $140 |
| Merck | 8 | $126 |
| AbbVie | 5 | $88 |
| Novartis | 4 | $69 |
| Johnson & Johnson | 4 | $67 |
| Boehringer Ingelheim | 2 | $44 |
| Lilly USA, LLC | 3 | $41 |
| AstraZeneca | 3 | $39 |
| Medtronic | 1 | $30 |
| Corcept Therapeutics | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| Bio Products Laboratory USA, Inc. | 1 | $21 |
| Harrow Eye, LLC | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| IBSA Pharma Inc. | 1 | $14 |
| Acorda Therapeutics, Inc | 1 | $14 |
| Amgen | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
How this compares
$1,287 in reported general payments places this provider in the 75th percentile of 9,771 internal medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carvedilol | 11 | $56 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Albany
- Scott BeegleAlbany$1.9M
- David DoveEast Hampton$12.3M
- Bruce BergerBrooklyn$3.4M
- Nicholas RobinsonBuffalo$2.9M
- Stephen SaletanNew York$2.6M
- Ziad AliNew York$2M
- Anthony MartinezBuffalo$1.6M
- Javier MoralesGreenvale$1.3M
- Ricky HsuNew York$1M
- James UnderbergNew York$953K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.